A rapid quantitative assay of intact paracetamol tablets by reflectance near-infrared spectroscopy

Abstract

Near-infrared (NIR) reflectance spectroscopy was used to determine rapidly and non-destructively the content of paracetamol in bulk batches of intact Sterwin 500 mg tablets by collecting NIR spectra in the range 1100–2500 nm and using a multiple linear regression calibration method. The developed NIR method gave results comparable to the British Pharmacopoeia 1993 UV assay procedure, the standard errors of calibration and prediction being 0.48% and 0.71% m/m, respectively. The method showed good repeatability, the standard deviation and coefficient of variation for six NIR assays on the same batch on the same day being 0.14 and 0.16% m/m, respectively, while measurements over six consecutive days gave 0.31 and 0.36% m/m, respectively. Applying the calibration to a parallel test set gave a mean bias of –0.22% and a mean accuracy of 0.45%. The developed method illustrates how the full potential of NIR can be utilised and how the ICH guidelines which recommend the validation of linearity, range, accuracy and precision for pharmaceutical registration purposes can be applied. Duplicate determinations on bulk batches could be performed in under 2 min, allowing the potential use of the method on-line for real time monitoring of a running production process.

References

1. A. F. Zappala and A. Post, J. Pharm. Sci., 1977, 66, 292.
2. P. Corti, E. Dreassi, G. Corbini, S. Lonardi, R. Viviani, L. Mosconi and M. Bernuzzi, Pharm. Acta Helv., 1990, 65, 28.
3. E. Dreassi, G. Ceramelli, P. Corti, P. L. Perruccio and S. Lonardi, Analyst, 1996, 121, 219.
4. E. Dreassi, G. Ceramelli, L. Savini and P. Corti, Analyst, 1995, 120, 319.
5. R. A. Lodder and G. M. Hieftje, Appl. Spectrosc., 1988, 42, 518.
6. R. Jensen, E. Peuchant, I. Castagne, A. M. Boirac and G. Roux, Spectrosc. Int. J., 1988, 6, 63.
7. J. Gottfries, H. Depui, M. Fransson, M. Jongeneelen, M. Josefson, F. W. Langkilde and D. T. Witte, J. Pharm. Biomed. Anal., 1996, 14, 1495.
8. S. M. Han and P. G. Faulkner, J. Pharm. Biomed. Anal., 1996, 14, 1681.
9. P. Merkle and K. A. Kovar, J. Pharm. Biomed. Anal., 1997, 17, 365.
10. A. Eustaquio, P. Graham, R. D. Jee, A. C. Moffat and A. D. Trafford, Analyst, 1998, 123, 2303.
11. M. Blanco, A. Eustaquio, R. D. Jee, and A. C. Moffat, Anal. Chim. Acta, in the press..
12. International Conference on Harmonisation (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use, Validation of Analytical Procedures: Methodology, Recommended for Adoption at step 4 of the ICH Process on 6 November 1996 by the ICH Steering Committee. Internet address: http://www.mcclurenet.com.
13. British Pharmacopoeia 1993, H.M. Stationery Office, London, 1993, vol. II, p. 1043.
14. R. J. Barnes, M. S. Dhanoa and S. J. Lister, Appl. Spectrosc., 1989, 43, 772.
15. S. A. Halsey, Technical Note, NIRSystems, Silver Spring, MD, 1994.
16. W. Caulcutt and R. Boddy, Statistics for Analytical Chemists, Chapman and Hall, London, 1983, p. 70.